Literature DB >> 3080295

Dissociated effects of misoprostol on gastric acid secretion and mucosal blood flow.

F W Leung, J C Miller, P H Guth.   

Abstract

Misoprostol, a synthetic prostaglandin analog, has been reported to inhibit gastric acid secretion and to protect the gastric mucosa from the effects of aspirin and aspirin plus hemorrhagic shock. This study examined the effect of misoprostol on basal gastric corpus mucosal blood flow (MBF), and on pentagastrin-stimulated gastric acid output and MBF. Gastric corpus MBF in ml/min/100 g was measured by hydrogen gas clearance in fasted, anesthetized rats. Acid output in mueq/min was determined by a continuous gastric perfusion technique. For the basal study, vehicle or misoprostol in doses of 50 and 1000 micrograms/kg was administered intragastrically in separate groups of rats. For the pentagastrin-stimulation study, vehicle or misoprostol, 1000 micrograms/kg, was infused intravenously after gastric acid output was stimulated to plateau by intravenous pentagastrin, 20 micrograms/kg/hr. The results showed that misoprostol had no effect on basal gastric corpus MBF. During pentagastrin stimulation, misoprostol decreased acid secretion but did not decrease gastric corpus MBF. We speculate that this dissociated effect of misoprostol on stimulated gastric acid secretion and corpus MBF may be of therapeutic importance if it can be confirmed in human studies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080295     DOI: 10.1007/bf01309329

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Protection of gastric mucosa against aspirin-induced erosions by enhanced blood flow.

Authors:  J M McGreevy; F G Moody
Journal:  Surg Forum       Date:  1977

2.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

3.  Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings].

Authors:  N K Boughton-Smith; J R Vane; B J Whittle
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

4.  Regional gastric mucosal blood flow measurements by hydrogen gas clearance in the anesthetized rat and rabbit.

Authors:  F W Leung; P H Guth; O U Scremin; E M Golanska; G L Kauffman
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

5.  Effect of prostaglandins on mucosal blood flow and aspirin-induced damage in the canine stomach.

Authors:  N Inatomi; Y Maki
Journal:  Jpn J Pharmacol       Date:  1983-12

6.  Cytoprotection of canine gastric mucosa by prostacyclin: possible mediation by increased mucosal blood flow.

Authors:  S J Konturek; A Robert
Journal:  Digestion       Date:  1982       Impact factor: 3.216

7.  Does gastric aminopyrine clearance reflect gastric mucosal blood flow or parietal cell function?

Authors:  S A Müller-Lissner; A Sonnenberg; A L Blum
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

8.  Effect of 16, 16-dimethyl PGE2 on resting and histamine-stimulated gastric mucosal blood flow.

Authors:  T A Miller; J M Henagan; A Robert
Journal:  Dig Dis Sci       Date:  1980-08       Impact factor: 3.199

9.  Canine gastric mucosal vasodilation with prostaglandins and histamine analogs.

Authors:  J G Gerber; A S Nies
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

10.  Comparison of prostacyclin and prostaglandin E2 on gastric secretion, gastrin release, and mucosal blood flow in dogs.

Authors:  S J Konturek; A Robert; A J Hanchar; J E Nezamis
Journal:  Dig Dis Sci       Date:  1980-09       Impact factor: 3.199

View more
  6 in total

Review 1.  Prostaglandins, H2-receptor antagonists and peptic ulcer disease.

Authors:  P Bright-Asare; T Habte; B Yirgou; J Benjamin
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.

Authors:  D Rachmilewitz; J W Chapman; P A Nicholson
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

3.  Effect of sucralfate on gastric mucosal blood flow in rats.

Authors:  B W Chen; W M Hiu; S K Lam; C H Cho; M M Ng; C T Luk
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

Review 4.  Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.

Authors:  J P Monk; S P Clissold
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

5.  Prostaglandin protection against hemorrhage-induced gastric stress ulceration in the rat.

Authors:  T Ranta-Knuuttila; T Kiviluoto; H Hyvärinen; A Lehtola; E Kivilaakso
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

6.  Role of gastric mucosal blood flow in gastroprotective effect of novel xanthine derivative.

Authors:  T Tanaka; P H Guth
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.